Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure

Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure

Aims. Soluble urokinase plasminogen activator receptor (suPAR) reflects the immune activation in circumstances of inflammation and infection. It has been considered as a risk biomarker associated with poor outcome in various low-grade inflammation and infectious diseases. The study is aimed at inves...

Full description

Bibliographic Details
Main Authors: Zuxiong Huang, Ning Wang, Shuiwen Huang, Yi Chen, Shida Yang, Qiaorong Gan, Hanhui Ye, Baorong Liu, Chen Pan
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/3467690

Similar Items

Similar Items